Page last updated: 2024-08-25

3-deazaneplanocin and Adrenocortical Carcinoma

3-deazaneplanocin has been researched along with Adrenocortical Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assié, G; Batisse-Lignier, M; Bertherat, J; Djari, C; Drelon, C; Lefrançois-Martinez, AM; Martinez, A; Mathieu, M; Pointud, JC; Ragazzon, B; Rodriguez, S; Sahut-Barnola, I; Septier, A; Tabbal, H; Tauveron, I; Val, P	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Adrenocortical Carcinoma

Article	Year
EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness. British journal of cancer, 2019, Volume: 121, Issue:5 Topics: Adenosine; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Cell Cycle Proteins; Cell Proliferation; Chromatin Immunoprecipitation; Computational Biology; E2F1 Transcription Factor; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Indoles; Mice, Knockout; Multivariate Analysis; Proportional Hazards Models; Ribonucleoside Diphosphate Reductase; Securin	2019

Article

Year

EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness.

British journal of cancer, 2019, Volume: 121, Issue:5

Topics: Adenosine; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Cell Cycle Proteins; Cell Proliferation; Chromatin Immunoprecipitation; Computational Biology; E2F1 Transcription Factor; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Indoles; Mice, Knockout; Multivariate Analysis; Proportional Hazards Models; Ribonucleoside Diphosphate Reductase; Securin

2019